Accentus Medical is pleased to announce the launch of its manufacturing capability for commercial supply of Agluna® anti-microbial surface technology for titanium medical implants.
Accentus Medical is pleased to announce the results of a retrospective review of near-term post-operative infection rates associated with orthopaedic limb salvage devices treated with its innovative Agluna® surface technology.
Accentus Medical has announced today the successful completion of a management buyout.
Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of Brian Howlett and Laurie Rostron to its board of directors.
Accentus Medical is pleased to announce that one of its customers, FHi, a member of the FH Orthopedics Group, recently gained a 510(K) approval from the US Food and Drug Administration for its Arrow Reverse Total Shoulder prosthesis. This product incorporates the proprietary Acusure® inert gas plasma spray coating, applied by Accentus Medical at our facility in Harwell.